This biotech currently has four drugs in mid to late-stage clinical trials. And any one that gets approved could send their share price skyrocketing. Institutional investors are taking notice...They more than doubled their stock purchases of the company in the final quarter of 2023...Do they know something you don't?
The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
Hey, I have an unique opportunity for those looking for additional ways to earn income right now. It can be done from home. You can do it in your spare time. And it only takes 6 clicks and as little as $50.
"If you're not at the table, you're on the menu," says former Goldman Sachs VP, Dr. David Eifrig.
Can you imagine earning $1,118,721/hr? That's what greedy Wall Street elites have been pocketing for 22 straight years. And now it's available to you.
In December 2023, 22 countries pledged to 3X their nuclear capacity. Sending these uranium stocks into a frenzy. Here's 1 uranium miner that exploration records show is sitting on 2.4 million pounds of uranium.